搜尋結果
Takeda's seizure drug fails to meet main goal in late-stage studies
Reuters· 5 日前Japan's Takeda said on Monday its experimental drug to treat epileptic disorders failed to ...
CNBC Daily Open: S&P 500 briefly crosses 5,500, closes lower
CNBC· 1 日前This report is from today's CNBC Daily Open, our international markets newsletter. The S&P ...
World Of Hyatt Adds 700+ Mr & Mrs Smith Boutique Hotels, More To Come
Forbes· 6 日前For fans of the World of Hyatt program, their world just got a lot bigger. In late April, the ...
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 1 日前Shares for Zealand Pharma rose by over 17% on Friday, after the Danish biotech firm announced positive trial results for ...
The Race to Fireproof Cities
Bloomberg· 2 日前Juniper trees are ecological marvels. Not only are junipers dense enough for privacy, but ...
Anthropic claims its latest model is best-in-class | TechCrunch
TechCrunch· 2 日前OpenAI rival Anthropic is releasing a powerful new generative AI model called Claude 3.5 Sonnet. Claude 3.5 Sonnet can analyze ...
Blondie’s Chris Stein On The Influential Band’s Career Via His New Memoir
Forbes· 5 日前In his newly-published autobiography Under a Rock, Blondie co-founding guitarist Chris Stein ...
CNBC Daily Open: S&P 500 crosses 5,500 level before erasing gains
CNBC· 2 日前This report is from today's CNBC Daily Open, our international markets newsletter. The S&P ...
How AI Is Accelerating Innovation In Research And Development
Forbes· 4 日前Innovation is increasingly intertwined with advancements in Artificial Intelligence. According ...
Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more
CNBC· 2 日前These are the stocks posting the largest moves midday.